Medigen Vaccine Biologics Corp.
21
0
2
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 21 trials
100.0%
+13.5% vs industry average
33%
7 trials in Phase 3/4
0%
0 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Long-Term Immunogenicity of Envacgen® in Children
Role: lead
A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
Role: lead
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
Role: lead
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222
Role: lead
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19
Role: lead
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19
Role: lead
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in Adults
Role: lead
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
Role: lead
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study
Role: lead
The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine
Role: collaborator
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults
Role: lead
A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study
Role: lead
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents
Role: lead
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
Role: lead
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19
Role: lead
A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult
Role: lead
A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19
Role: collaborator
A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine
Role: lead
A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan
Role: lead
A Clinical Study for Inactivated Vaccine Against EV71
Role: lead